Ophthalmologist's note (custom)

History: Chief Complaint: Patient presents with blurred vision in the left eye. History of Present Illness: Patient reports the onset of blurred vision in the left eye approximately one week ago. The blurriness is intermittent, described as a 'shadow' across their vision, and is more pronounced in the morning. The severity is rated as a 4/10 on a pain scale. The character of the visual complaint is described as a 'shadow' across their vision. Past Ocular History: * No prior history of eye diseases or surgeries. Medical History: * Patient reports a history of hypertension, well-controlled with medication. Medication History: * Amlodipine 5mg daily. Allergies: * No known drug allergies. Family Ocular History: * Mother has a history of glaucoma. Social History: * Non-smoker. Drinks alcohol occasionally. Examination: Visual Acuity: * Unaided: OD 20/20, OS 20/40 * Aided: OD 20/20 with correction, OS 20/25 with correction * Pinholes: OD improves to 20/20, OS improves to 20/30 Intraocular Pressure: * Tonometry: OD 16 mmHg, OS 18 mmHg Anterior Segment: * OD: Clear cornea, deep and quiet anterior chamber, reactive pupil. * OS: Clear cornea, deep and quiet anterior chamber, reactive pupil. Posterior Segment: * OD: Optic disc appears healthy, no hemorrhages or exudates, normal cup-to-disc ratio. Macula flat. * OS: Optic disc appears healthy, no hemorrhages or exudates, normal cup-to-disc ratio. Macula flat. Additional Tests / Scans: * Visual fields: Full to confrontation. Assessment: Patient presents with blurred vision in the left eye. The most likely diagnosis is early cataract formation, with a secondary differential diagnosis of mild macular degeneration. Plan: Treatments: * Discussed the option of cataract surgery. Follow-Up: Patient to return in 6 months for a follow-up examination. Patient Education: * Discussed the diagnosis of early cataract formation and the potential for progression. * Explained the treatment options, including observation and surgery. Referrals: * No referrals required at this time. Date: 1 November 2024